标题
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
作者
关键词
-
出版物
ANNALS OF INTERNAL MEDICINE
Volume 176, Issue 1, Pages 59-66
出版商
American College of Physicians
发表日期
2022-12-06
DOI
10.7326/m22-2115
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States
- (2022) Kirsten L. Johansen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide ‐1 receptor agonists: A narrative review and proposed clinical approach
- (2022) Meir Schechter et al. DIABETES OBESITY & METABOLISM
- Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial
- (2022) et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
- (2021) Pardeep S. Jhund et al. CIRCULATION
- Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
- (2021) Hiddo J L Heerspink et al. EUROPEAN HEART JOURNAL
- Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure
- (2021) Michael Szarek et al. ANNALS OF INTERNAL MEDICINE
- Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis
- (2021) Kent Y. Feng et al. DIABETES OBESITY & METABOLISM
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
- (2021) Kohei Kaku et al. DIABETES OBESITY & METABOLISM
- Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure
- (2020) Gregory A. Nichols et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway
- (2020) Jun Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- Hospitalizations among adults with chronic kidney disease in the United States: A cohort study
- (2020) Sarah J. Schrauben et al. PLOS MEDICINE
- Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
- (2020) Darren K McGuire et al. Lancet Diabetes & Endocrinology
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
- (2018) Claudio R. Scafoglio et al. Science Translational Medicine
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional expression of sodium-glucose transporters in cancer
- (2015) Claudio Scafoglio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risks of Subsequent Hospitalization and Death in Patients with Kidney Disease
- (2012) K. B. Daratha et al. Clinical Journal of the American Society of Nephrology
- Effect of Chronic Kidney Disease and Comorbid Conditions on Health Care Costs: A 10-Year Observational Study in a General Population
- (2009) Sebastian E. Baumeister et al. AMERICAN JOURNAL OF NEPHROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started